OLUKOTUN ADEOYE Y 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Dec 30, 2024
Insider Transaction Report
Form 4
OLUKOTUN ADEOYE Y
Director
Transactions
- Sale
Common Stock
2024-12-27$20.00/sh−2,850$57,000→ 36,740 total
Footnotes (2)
- [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.